Atossa Therapeutics Inc (NASDAQ: ATOS) announced two abstracts featuring its drug candidate (Z)-endoxifen have been accepted for presentation at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE